News

2015 ACR RA guidelines criticized on steroid, HBV screening, cancer history advice

Publish date: February 25, 2016

 

References

None of these authors reported funding sources or conflicts of interest.

Pages

Recommended Reading

ACR: Etanercept during pregnancy doubles the odds of major malformations
MDedge Internal Medicine
ACR: The pain of inflammatory disease goes beyond the physical
MDedge Internal Medicine
New case of MS possibly related to tocilizumab
MDedge Internal Medicine
ACR: Push back when insurance decisions force TNFi change
MDedge Internal Medicine
Step therapy and biologics: An easier road ahead?
MDedge Internal Medicine
Rituxan led Medicare part B drug spending in 2014
MDedge Internal Medicine
Biosimilar infliximab gains FDA Advisory Committee endorsement
MDedge Internal Medicine
Greater myocardial inflammation found in RA patients after heart attack
MDedge Internal Medicine
Biosimilar program reshapes FDA’s objectivity
MDedge Internal Medicine
Once-daily tofacitinib formulation gets FDA clearance for RA
MDedge Internal Medicine